Immune Regulation News 8.27 July 29, 2016 | |
| |
TOP STORYResearchers report that the inflammatory cytokine interleukin-6 (IL-6) actively repressed Eos expression through microRNA-17 (miR-17). miR-17 expression increased in regulatory T cells in the presence of IL-6, and its expression negatively correlated with that of Eos. [Immunity] Abstract | Graphical Abstract | |
| |
PUBLICATIONS(Ranked by impact factor of the journal)Scientists showed that bone marrow cells transiently stimulated in vivo or in vitro through the Toll-like receptor 9 generate proB cells that interrupt experimental autoimmune encephalomyelitis when transferred at the onset of clinical symptoms. [Nat Commun] Full Article Researchers demonstrated that cord blood contains an abundance of B cells with immunoregulatory function. Regulatory B cells were identified in both the naïve and transitional B cell compartments and suppressed T-cell proliferation and effector function through IL-10 production as well as cell-to-cell contact involving CTLA-4. [Blood] Abstract Peripheral Tolerance Can Be Modified by Altering KLF2-Regulated Treg Migration Investigators report that transcription factor Kruppel-like factor 2 (KLF2) controls naive Treg migration patterns via regulation of homeostatic and inflammatory homing receptors, and that in its absence KLF2-deficient Tregs are unable to migrate efficiently to secondary lymphoid organs. [Proc Natl Acad Sci USA] Abstract Inflammatory Th17 Cells Express Integrin αvβ3 for Pathogenic Function Scientists report that pro-inflammatory Th17 cells express high integrin β3 that is interleukin-23 dependent. Integrin β3 was not upregulated on all activated T cells; rather, integrin β3 was upregulated along with its functional partner integrin αv on effector Th17 cells and “ex-Th17” cells, and αvβ3hi RORγt+ cells expanded during experimental autoimmune encephalomyelitis. [Cell Rep] Full Article | Graphical Abstract Minocycline Promotes the Generation of Dendritic Cells with Regulatory Properties Investigators showed that minocycline significantly enhances the generation of dendritic cells from mouse bone marrow cells when used together with GM-CSF and IL-4. [Oncotarget] Full Article The authors demonstrated that exhausted T cells with inhibitory receptors are significantly increased in the melanoma-bearing mice. Meanwhile, the differentiated miRNA profiles in PD1+ exhaustive T cells were identified using a miRNA array; 11 miRNAs were observed with significant altered levels in the exhausted T cells isolated from melanoma-bearing mice. [Oncotarget] Full Article c-Src Suppresses Dendritic Cell Antitumor Activity via T Cell Ig and Mucin Protein-3 Receptor The authors identified a novel signaling pathway necessary for T cell Ig and mucin protein-3 (TIM-3) upregulation on dendritic cells (DCs). Both IL-10 and TGF-β, which are produced in the tumor microenvironment, upregulated TIM-3 expression on DCs via this pathway. [J Immunol] Abstract Zinc Induces Dendritic Cell Tolerogenic Phenotype and Skews Regulatory T Cell–Th17 Balance Scientists investigated the effect of zinc (Zn) on dendritic cell (DC) phenotype and the generation of Foxp3+ regulatory T cells using a model of Histoplasma capsulatum fungal infection. Exposure of bone marrow–derived DCs to Zn in vitro induced a tolerogenic phenotype by diminishing surface MHC class II and promoting the tolerogenic markers, programmed death–ligand (PD-L)1, PD-L2, and the tryptophan degrading enzyme, IDO. [J Immunol] Abstract Subscribe to our sister publications: Human Immunology News & Immunology of Infectious Disease News. | |
| |
REVIEWST Follicular Helper (TFH) Cell Programming by Cytokine-Mediated Events Researchers summarize what is known regarding the role of cytokines in both the promotion and inhibition of TFH cell differentiation and function. [Immunology] Abstract | Full Article Immune Regulation in Chronic Hepatitis C Virus Infection The authors provide an overview of regulatory functions of hepatitis C virus (HCV)-specific T cells, NK cells, Tregs, IL-10, and TGF-β, as well as epigenetic changes in the setting of chronic HCV infection. [Scand J Gastroenterol] Abstract Visit our reviews page to see a complete list of reviews in the immune regulation research field. | |
| |
INDUSTRY NEWSAbbVie and Bristol-Myers Squibb Company announced a clinical trial collaboration to evaluate the safety, tolerability and efficacy of AbbVie’s investigational biomarker-specific antibody drug conjugate Rova-T in combination with Bristol-Myers Squibb’s Opdivo and Opdivo + Yervoy regimen as a treatment for relapsed extensive-stage small cell lung cancer. [AbbVie] Press Release X-Chem and AbbVie Enter into Multi-Target Drug Discovery Partnership X-Chem, Inc. announced a multi-target drug discovery agreement with AbbVie. The collaboration is focused on the discovery and development of novel treatments for diseases in oncology and immunology. [X-Chem, Inc.] Press Release | |
| |
POLICY NEWSMajor Review Calls Time on Gaming in UK Research Assessment The UK’s mammoth periodic audit of its research is set for a shake-up that could change the way universities hire academics – and might also encourage scientists to spend more time on public engagement. [Nature News] Editorial Meet Europe’s New Science Advice Brigade Too many cooks spoil the broth, goes the saying. Could too many advisers spoil the advice? On the contrary, say the seven scientists who front the European Commission’s new Scientific Advice Mechanism, and who collectively replaced the single-headed role of chief scientific adviser last year. [ScienceInsider] Editorial Trump vs Clinton: Worlds Apart on Science Science is slowly coming into focus in the US presidential campaign. Although neither Republican Donald Trump nor Democrat Hillary Clinton has emphasized core research issues, the candidates — and their parties — are beginning to flesh out their positions on climate change, education, biomedical research and other topics that involve the scientific community. [Nature News] Editorial Public Is Wary of Using Technologies to Enhance Human Performance, Survey Finds A new poll finds that Americans have serious questions about the use of new technologies to enhance the lives of healthy people. Those with strong religious beliefs are especially troubled by the prospect of such enhancements, seeing them as meddling with nature. [ScienceInsider] Editorial Scientific Literature: Information Overload Recent bibliometrics show that the number of published scientific papers has climbed by 8–9% each year over the past several decades. In the biomedical field alone, more than 1 million papers pour into the PubMed database each year — about two papers per minute. For researchers who are already overwhelmed by bench and field work, grant-writing, publishing and other time-eaters, trying to navigate the growing deluge of data has become a second job. [Nature Careers] Editorial | |
| |
EVENTSNEW Adoptive T-Cell Therapy Summit 2016 NEW T-ALL Workshop Visit our events page to see a complete list of events in the immune regulation community.
| |
JOB OPPORTUNITIESNEW Lecturer – Immunology (University of Edinburgh) NEW Postdoctoral Position – Tumor Immunology (Roswell Park Cancer Institute) Technical Sales Representative (STEMCELL Technologies Inc.) Research Technologist – Cell Separation (STEMCELL Technologies Inc.) Scientist – Bioengineering (STEMCELL Technologies Inc.) Senior Scientist – Immunology and Cell Separation (STEMCELL Technologies Inc.) Postdoctoral Position – Immunology (Inserm) Postdoctoral Fellow – Cancer Biology and Cancer Immunology (Fox Chase Cancer Center) Senior Faculty Leadership Position – Immunology (Fred Hutchinson Cancer Research Center) Postdoctoral Position – Immunology (Ludwig-Maximilians-Universität) Assistant or Associate Professor – Cancer Immunology (University of Virginia) Research Postdoctoral Fellow – Molecular Immunology/Cell Signaling (Baylor Scott & White Health) Postdoctoral Scientist – Novel Immune Modulating Drugs (Celentyx) Recruit Top Talent: Reach potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.
| |
Have we missed an important article or publication in Immune Regulation News? Click here to submit! Comments or suggestions? Submit your feedback here. | |
|